Author(s):
Ruslin, Mesi Leorita, Nur Arifa, Yamin, Suryani, Henny Kasmawati, Sunandar Ihsan, Andi Nafisah Tendri Adjeng
Email(s):
mahaleo241@yahoo.co.id
DOI:
10.5958/0974-360X.2020.00503.X 
Address:
Ruslin*, Mesi Leorita, Nur Arifa, Yamin, Suryani, Henny Kasmawati, Sunandar Ihsan, Andi Nafisah Tendri Adjeng
Department of Pharmacy, Faculty of Pharmacy, Universitas Halu Oleo, Kendari, South-East Sulawesi, 93232, Indonesia.
*Corresponding Author
Published In:
Volume - 13,
Issue - 6,
Year - 2020
ABSTRACT:
Cancer is disease characterized by uncontrolled cell division and the ability of the cells to attack other biological tissues. Leonurine is a compound obtained from the Siberian motherwort (Leonurus artemisia L.) that can inhibit cancer cells growth. The discovery of this compound by means of synthesis has been developed using computational chemistry. One of the techniques that have been developed is in silico method. The purposes of this study were to find out the ability of leonurine and its derivatives to eliminate the Cyclin-Dependent Kinase-2 (CDK-2 enzyme) as a requirement for anticancer agents and to find out whether leonurine and its derivatives are good substances for anticancer drugs. Leonurine derivatives were formed using ChemDraw Ultra 8.0, HyperChem, Open Babel 2.3.2, then docked using AutoDock 4.2, and visualized using Discovery Studio Visualizer in order to see the interaction between macromolecular ligands and CDK-2 obtained from (Protein Data Bank) PDB sites. From the in silico study, 15 derivatives of leonurine were found and the derivative-9 has good potential as candidate for anticancer drug with Energy Binding (?G) values of -7.81 kcal/mol.
Cite this article:
Ruslin, Mesi Leorita, Nur Arifa, Yamin, Suryani, Henny Kasmawati, Sunandar Ihsan, Andi Nafisah Tendri Adjeng. Potential Anticancer role of Leonurine and its Derivatives. Research J. Pharm. and Tech 2020; 13(6): 2825-2832. doi: 10.5958/0974-360X.2020.00503.X
Cite(Electronic):
Ruslin, Mesi Leorita, Nur Arifa, Yamin, Suryani, Henny Kasmawati, Sunandar Ihsan, Andi Nafisah Tendri Adjeng. Potential Anticancer role of Leonurine and its Derivatives. Research J. Pharm. and Tech 2020; 13(6): 2825-2832. doi: 10.5958/0974-360X.2020.00503.X Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-6-53
REFERENCES:
1. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011; 331(6024): 1559-1564
2. Khanage SG, Mohite PB, Raju SA. Synthesis, anticancer and antibacterial activity of some novel 1, 2, 4-triazole derivatives containing pyrazole and tetrazole rings. Asian J Res Chem. 2011;4(4):567–73.
3. Soediono B. Situasi Penyakit Kanker. J Chem Inf Model. 1989; 53:160.
4. Saha D, Tamrakar A. Xenobiotics, Oxidative Stress, Free Radicals Vs. Antioxidants: Dance of Death to Heaven’s Life. Asian J Res Pharm Sci. 2011;1(2):36–8.
5. Ruslin, Kartasasmita RE, Wibowo MS, Ibrahim S. Pharmacokinetic properties and binding affinity prediction of leonurine and its derivatives design on phospodiesterease-5. Int J Res Pharm Sci. 2014; 5(1): 7-13.
6. Mazimba O. Leonotis leonurus : A herbal medicine review. J Pharmacogn Phytochem. 2015; 3(6): 74-82.
7. Shankari B, Rambabu M, Jayanthi S. Claudin-7 Inhibitors for Colon Cancer: A Computational Approach. Res J Pharm Technol. 2018;11(8):3415–8.
8. Kapetanovic IM. Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach. Chem Biol Interact. 2008 Feb 1; 171:165–76.
9. Morris GM, Ruth H, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009; 30(16): 2785-2791.
10. Krishnasamy L, Selvam MM, Ravikrishnan B. Anticancer property of Colchicine isolated from Indigofera aspalathoids. Res J Pharm Technol. 2016;9(4):386.
11. Akaho E, Fujikawa C, Runion Hi, Hill Cr, Nakano H. A Study on Binding Modes of Nonsteroidal Anti-inflammatory Drugs to COX1 and COX2 as Obtained by Dock4.0. J Chem Softw. 1999; 5(4): 147-162.
12. Schneider G, Baringhaus K-H. Molecular design. Concepts and applications. RECIIS. 2008; 3(2):79-80.
13. Morris GM, Lim-Wilby M. Molecular docking. Methods Mol Biol. 2008; 443: 365-382.
14. Chelamalla R, Makula A. Molecular docking studies and ADMET predictions of pyrimidine coumarin scaffolds as potential IDO inhibitors. Asian J Res Chem. 2017;10(3):331–40.
15. Thomas R, Hari R, Joy J, Krishnan S, Swathy AN, Nair SS, et al. In silico Docking Approach of Coumarin Derivatives as an Aromatase Antagonist. Res J Pharm Technol. 2015;8(12):1673.
16. Hemalatha K, Chakkaravarthi V, Murthy KG, Kayatri R, Girija K. Molecular Properties and Docking Studies of Benzimidazole Derivatives as Potential Peptide Deformylase Inhibitors. Asian J Res Chem. 2014;7(7):3.
17. Du X, Li Y, Xia YL, Ai SM, Liang J, Sang P, et al. Insights into protein–ligand interactions: Mechanisms, models, and methods. International Journal of Molecular Sciences. 2016;17 (2):144-178.
18. Kumar RS, Basha SN, Nallasivan PK, Solomon WD, Venkatnarayanan R. Computer Aided Docking Studies on Antiviral Drugs for Bird Flu. Asian J Res Chem. 2010;3(2):370–3.
19. Ferreira De Freitas R, Schapira M. A systematic analysis of atomic protein-ligand interactions in the PDB. Medchemcomm. 2017; 8(10):1970-1981.
20. Sharp KA, Honig B. Electrostatic interactions in macromolecules: Theory and applications. Annual Review of Biophysics and Biophysical Chemistry. 1990; 19 (1): 301-332.
21. Berg J, Tymoczko J, Stryer L. Chemical Bonds in Biochemistry. In: Biochemistry. 2002; pp: 8-14.
22. Boyle J. Lehninger Principles of Biochemistry (4th ed.): Nelson, D., and Cox, M. Biochem Mol Biol Educ. 2005; 33(1): 74-75.
23. Chandran M, George S, Santhalingam K, Gangwar P. Molecular Docking of 3, 5, 7-Trihydroxy-2-(4-Hydroxy-3-Methoxyphenyl)-4h-Chromen-4-One Derivatives Against Il-6 for Rheumatoid Arthritis. Asian J Res Chem. 2011;4(8):1254–7.
24. Prashanthi G, Kumar YP, Latha DS, Pramod N, Gopinath C. Synthesis, Characterization, Docking and Biological Evaluation of Tetra Hydro Imidazo [1, 2-a] Pyrazine Derivatives. Asian J Res Chem. 2016; 9(6):271–6.
25. Hubbard RE, Kamran Haider M. Hydrogen bonds in proteins: role and strength. e LS. 2001; pp:1-7.